January 2008
M	T	W	T	F	S	S
« Dec		Feb »
1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Medical Articles 1/31

Posted by rob on January 31, 2008 under Uncategorized | Be the First to Comment

Solution NMR structure of the N-terminal domain of the human DEK protein.

Synthesis
and in vitro antitumoral activity of novel
O,O’-di-2-alkyl-(S,S)-ethylenediamine-N,N’-di-2-propanoate ligands and
corresponding platinum(II/IV) complexes.

Leukemic cell infiltration into the large intestine in a patient with acute myelogenous leukemia.

Mesenchymal
stem cells in patients with chronic myelogenous leukaemia or
bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic
clone.

Long-term
outcome of complete cytogenetic responders after imatinib 400 mg in
late chronic phase, philadelphia-positive chronic myeloid leukemia: the
GIMEMA Working Party on CML.

Bone marrow transplant relapse with loss of an allele.

Durable
responses in chronic myeloid leukemia patients maintained with lower
doses of imatinib mesylate after achieving molecular remission.

Acute
myeloid leukemia developing during imatinib mesylate therapy for
chronic myeloid leukemia in the absence of new cytogenetic
abnormalities.

Epigenetic regulation of PRAME gene in chronic myeloid leukemia.

Medical Articles 1/25

Posted by rob on January 26, 2008 under Uncategorized | Be the First to Comment

Platelet functions and clinical effects in acute myelogenous leukemia.

Reduced-intensity
conditioning followed by allogeneic hematopoietic cell transplantation
for adult patients with myelodysplastic syndrome and myeloproliferative
disorders.

HLA-identical
sibling allogeneic transplants versus chemotherapy in acute myelogenous
leukemia with t(8;21) in first complete remission: collaborative study
between the German AML Intergroup and CIBMTR.

Hematopoietic
stem cell transplantation after reduced intensity conditioning in acute
myelogenous leukemia patients older than 40 years.

The
role of cytotoxic therapy with hematopoietic stem cell transplantation
in the therapy of acute myelogenous leukemia in adults: an
evidence-based review.

Current status of antivascular therapy and targeted treatment in the clinic.

The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias.

Primary dermal melanoma occurring in a patient affected by Philadelphia-positive chronic myeloid leukaemia.

Medical Articles 1/23

Posted by rob on January 23, 2008 under Uncategorized | Be the First to Comment

Granulocytic Sarcomas Evaluated With F-18-Fluorodeoxyglucose PET.

Translocation
3;21, trisomy 8, and duplication of the Philadelphia chromosome: a rare
but recurrent cytogenetic pathway in the blastic phase of chronic
myeloid leukemia.

The
short arm of chromosome 18 is a recurrent integration site of a
supernumerary BCR/ABL gene fusion in chronic myeloid leukemia.

Conventional
and fluorescence in situ hybridization analysis of three-way complex
BCR-ABL rearrangement in a chronic myeloid leukemia patient.

[No influence of imatinib on type 2 diabetes]

Medical Articles 1/22

Posted by rob on January 22, 2008 under Uncategorized | Be the First to Comment

The biological characteristics of dendritic cells derived in vitro from myelogeneous leukemia cells and healthy donor cells.

[Huge brain abscess and invasive pulmonary disease by fungal infection during chemotherapy for infantile acute myeloid leukemia]

Medical Articles 1/19

Posted by rob on January 19, 2008 under Uncategorized | Be the First to Comment

Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia.

RUNX1
DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+
leukemias are frequently associated with secondary trisomy 21 and may
contribute to clonal evolution and imatinib resistance.

CXCR4
up-regulation by imatinib induces chronic myelogenous leukemia (CML)
cell migration to bone marrow stroma and promotes survival of quiescent
CML cells.

Medical Articles 1/15

Posted by rob on January 15, 2008 under Uncategorized | Be the First to Comment

Overexpression/enhanced
kinase activity of BCR/ABL and altered expression of Notch1 induced
acute leukemia in p210BCR/ABL transgenic mice.

AML1 mutations induced MDS and MDS/AML in a mouse BMT model.

Switching of donor cells after urgent second cord blood transplantation for suspected graft failure.

Successful
combined use of tranexamic Acid and unfractionated heparin for
life-threatening bleeding associated with intravascular coagulation in
a patient with chronic myelogenous leukemia in blast crisis.

Conjunctival hemorrhagic events associated with imatinib mesylate.

HOXA10 expression induced by Abl kinase inhibitors enhanced apoptosis through PI3K pathway in CML cells.

[Acute megakarioblastic leukemia: de novo and transformation of chronic myeloid leukemia]

Medical Articles 1/10

Posted by rob on January 10, 2008 under Uncategorized | Be the First to Comment

Long-term
experience with imatinib therapy in chronic phase chronic myelogenous
leukemia-Remarkable activity with room for improvement.

BCR-ABL1 mediates upregulation of Fyn in chronic myelogenous leukemia.

Association
with the presence of naive T cells in chronic myeloid leukemia patients
after allogeneic human stem cell transplantation and the lower
incidence of chronic graft-versus host disease and relapse.

Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).

Medical Articles 1/9

Posted by rob on January 9, 2008 under Uncategorized | Be the First to Comment

A
review of the role of benzene metabolites and mechanisms in malignant
transformation: Summative evidence for a lack of research in
nonmyelogenous cancer types.

Deguelin Represses Both the Expression of Nucleophosmin and some Nucleoporins: Nup88 and Nup214 in Jurkat Cells.

[Kinetics
of proliferation, differentiation and transcription of genes regulating
apoptosis in cultured human BCR/ABL+ Ph+-cells]

Overdose with 6400 mg of imatinib: is it safe?

Betanin
a betacyanin pigment purified from fruits of Opuntia ficus-indica
induces apoptosis in human chronic myeloid leukemia Cell line-K562.

Medical Articles 1/5

Posted by rob on January 5, 2008 under Uncategorized | Be the First to Comment

andutinib, an oral, small-molecule inhibitor of FLT3 for the treatment of AML and other cancer indications.

Squamous
cell carcinoma of the tongue after bone marrow transplant and
graft-versus-host disease: a case report and review of the literature.

Medical Articles 1/3

Posted by rob on January 3, 2008 under Uncategorized | Be the First to Comment

[Current status and future perspective of new drugs for hematological malignancies in Japan]

[Trends in molecular targeting therapeutics for chronic myeloid leukemia]

[Influence
of graft-versus-host disease on long-term survival of 26 patients with
hematologic malignancies after transplantation]

[Effects
of combined therapy of human leucocyte antigen haploidentical related
bone marrow transplantation and Chinese medicine in treating leukaemia]

Archives

Recent Posts

Meta